GC Medical Science KRX:142280KOSDAQ
녹십자엠에스 · Korean news coverage and regulatory filings, organized.
In Q3 2026, GC Medical Science reported revenue of ₩27.0bn, up 2.3% year on year, and operating profit of ₩1.1bn. GC Medical Science (녹십자엠에스) appeared in 0 Korean news articles and 2 DART filings over the past seven days.
Filing signals Insider buying Screener
GC Medical Science at a glance from DART filings
- Results trend
- Operating profit in each of the last 4 quarters; Q3 2026 operating profit of ₩1.1bn rose from the previous quarter.
- Ownership changes
- 3 5%-holder and insider ownership reports in the past 120 days (2 increases, 1 decreases).
Figures the company filed on DART, grouped by ATS View. Not a buy or sell call; see the cards below and the DART originals.
GC Medical Science today: up or down?
No sign-up, one tap a day. These numbers show what visitors think and are not investment advice.
Upcoming dates as filed
- Mar 31 Annual report filing deadlinein 134 days · period ending Dec 2026
Dates GC Medical Science stated in its DART filings. A conversion period opening does not mean new shares appear that day; bondholders must request conversion.
GC Medical Science quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q3 2026 | ₩27.0bn | +2.3% | ₩1.1bn margin 4.2% | −₩1.5bn |
| Q2 2026 | ₩27.1bn | -10.9% | ₩743m margin 2.7% | −₩4.0bn |
| Q1 2026 | ₩23.6bn | -11.1% | ₩292m margin 1.2% | ₩221m |
| Q4 2025 derived | ₩25.0bn | -9.7% | ₩390m margin 1.6% | ₩333m |
| Q3 2025 | ₩26.4bn | -1.8% | ₩944m margin 3.6% | ₩1.4bn |
| Q2 2025 | ₩30.4bn | +19.5% | ₩1.1bn margin 3.5% | ₩2.4bn |
| Q1 2025 | ₩26.5bn | +11.7% | ₩495m margin 1.9% | −₩727m |
| Q4 2024 derived | ₩27.8bn | +17.5% | ₩971m margin 3.5% | ₩2.1bn |
GC Medical Science ranks #1086 of 2,345 Korean listed companies by Q3 2026 operating profit. Q3 2026 Korean earnings rankings →
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
GC Medical Science top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.
Latest GC Medical Science news Korean headlines
-
Concerns over Russian plague outbreak bolster International Vaccine and GC MS [Why Biotech]
1 more on this story · 1 outlets